Market Overview

JPMorgan Diagnoses The MedTech Space: Stock Picks And Pans


The medical technology space for the most part benefited throughout 2017 and heading into 2018 some Wall Street analysts remain bullish.

The Analyst

JPMorgan's Michael Weinstein.

The Thesis

2017 was a positive year for the MedTech space and was able to overcome multiple challenges, including tough comparisons, a disruption in terms of manufacturing and demand from hurricanes, and a rising interest rates, Weinstein said in a note. But looking towards 2018, the industry-wide fundamentals are strong and sector revenue growth could re-accelerate from 4.4 percent last year to 5.1 percent in the new year.

Specifically, 2018 will be favorable for the group due to the release of new products, an economic backdrop that is "as good as it gets" with consumer confidence at a 17-year high and unemployment at a 10-year low, and tax reform and forced repatriation could create a new round of buybacks and M&A.

Here is a summary of the firm's top picks and pans.

  • Top large-cap picks: 1) Baxter International Inc (NYSE: BAX), 2) Zimmer Biomet Holdings Inc (NYSE: ZBH)
  • Top small-cap picks: 1) Intersect ENT Inc (NASDAQ: XENT), 2) Irhythm Technologies Inc (NASDAQ: IRTC)
  • Names with Underweight ratings: Accuray Incorporated (NASDAQ: ARAY), ConforMIS Inc (NASDAQ: CFMS), Endologix, Inc. (NASDAQ: ELGX)

Related Links:

5 Hot Stocks To Start 2018

The Week Ahead: New Year Still Presents Some Earnings And Other Catalysts

Posted-In: Hurricanes JPMorgan Medical Technology Medtech Michael WeinsteinAnalyst Color Analyst Ratings Trading Ideas


Related Articles (ARAY + BAX)

View Comments and Join the Discussion!
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Jon Najarian Sees Unusual Options Activity In BlackBerry, Microsoft, And Waste Management

Macquarie: In The Content Wars, Disney 'By Far' The Most Likely To Succeed